Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check6 days agoChange DetectedThe page's revision marker was updated from v3.5.3 to v3.5.4, indicating a version update in the page's metadata.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThis updates the site’s displayed revision/version label for the ClinicalTrials.gov page (from v3.5.2 to v3.5.3) without changing the study content.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded the term Malignant fibrous histiocytoma to related terms and added Genetic and Rare Diseases Information Center as a resources reference.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to core study details or user-facing content.SummaryDifference0.0%

- Check70 days agoChange DetectedPage revision updated to v3.4.3 (March 2026); prior revision details (v3.4.2) and September 2025 entries were removed.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.